Company overview
Basic information
Company name
Andriaus ūkis, MB
Company code
307186635
VAT code
LT100018894919
Registered address
Alytaus r. sav., Pivašiūnų sen., Junčionių k., Liepų g. 17, LT-64485
Registration date
2025-05-29
Company age: 1 y. 5 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Email
Presented as an image – cannot be copied
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Small partnership
NACE activity
Growing of cereals, other than rice, leguminous crops and oil seeds
Ownership form
Private without foreign capital
Mažoji bendrija "Andriaus ūkis"
Company code: 307186635
Address: Alytaus r. sav., Pivašiūnų sen., Junčionių k., Liepų g. 17, LT-64485
VAT code: LT100018894919
Description
This description was generated by artificial intelligence.
Andriaus ukis, MB (company code 307186635) is a private small partnership registered on 29 May 2025 and currently operational. It is classified as a micro-sized private non-financial company with Lithuanian private ownership and CEO-only governance. The company operates in agriculture under EVRK code A.01.11.00, with the activity described as growing of cereals, other than rice, leguminous crops and oil seeds. Its registered address is Liepu g. 17, Juncioniu k., Pivašiunu sen., Alytaus r. sav., Alytaus County, Lithuania. Financially, the latest available year is 2025, covering 216 days of activity. In that period, the company generated EUR 10.7K in revenue and EUR 4.9K in net profit, corresponding to a 46.0% profit margin. Equity and total assets were both EUR 6.7K, indicating a fully equity-financed balance sheet. The company’s latest available financial ratios also show strong returns on equity and assets. Staff information for so far in 2026 is not reported in the provided data.
Download a detailed company report
Make confident decisions with all the information about Andriaus ūkis, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.